MedCap - Public Comps and Valuation Multiples

MedCap Overview

About MedCap

MedCap AB acquires and develops profitable, market-leading niche companies in the Nordic life science industry. It is diversified into two business areas namely Medical technology and Specialist medicines. Medical Technology mainly develops and sells various medical technology products and services. Its Specialist medicines develop and sell medicines within the regulatory classes of registered, extemporaneous and licensed medicines.

Founded

HQ

Employees

270

Website

medcap.se

Sectors

Medical Devices
HealthTech

Financials

LTM Revenue $209M

LTM EBITDA $44.2M

EV

$876M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

MedCap Financials

As of September 2025, MedCap reported last 12-month revenue of $209M and EBITDA of $44.2M.

In the same period, MedCap generated $122M in LTM gross profit and $22.7M in net income.

See MedCap valuation multiples based on analyst estimates

MedCap P&L

In the most recent fiscal year, MedCap reported revenue of $190M and EBITDA of $41.6M.

MedCap expects next 12-month revenue of XXX and NTM EBITDA of XXX

See MedCap valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$209M	XXX	$190M	XXX	XXX	XXX
Gross Profit	$122M	XXX	$111M	XXX	XXX	XXX
Gross Margin	58%	XXX	59%	XXX	XXX	XXX
EBITDA	$44.2M	XXX	$41.6M	XXX	XXX	XXX
EBITDA Margin	21%	XXX	22%	XXX	XXX	XXX
EBIT	$30.6M	XXX	$25.3M	XXX	XXX	XXX
EBIT Margin	15%	XXX	13%	XXX	XXX	XXX
Net Profit	$22.7M	XXX	$21.8M	XXX	XXX	XXX
Net Margin	11%	XXX	11%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for MedCap including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $209M. EBITDA for the last twelve months was $44.2M. In the most recent fiscal year, MedCap achieved $190M in revenue and $41.6M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$209M	Analyst estimates available to subscribers	$190M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$122M	Analyst estimates available to subscribers	$111M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	58.1% gross margin	Analyst estimates available to subscribers	58.5% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$44.2M	Analyst estimates available to subscribers	$41.6M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	21.1% EBITDA margin	Analyst estimates available to subscribers	21.9% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$30.6M	Analyst estimates available to subscribers	$25.3M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	14.6% EBIT margin	Analyst estimates available to subscribers	13.3% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$22.7M	Analyst estimates available to subscribers	$21.8M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	10.8% net profit margin	Analyst estimates available to subscribers	11.5% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for MedCap

This financial data table provides comprehensive performance metrics for MedCap, a company based in Sweden. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

MedCap generated $209M in revenue over the last twelve months.
The company achieved $44.2M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $122M.
Net income over the last twelve months reached $22.7M.

Fiscal Year Performance

In the most recent fiscal year, MedCap reported $190M in total revenue.
Fiscal year EBITDA was $41.6M.
The company maintained a gross profit margin of 58.5% in the most recent fiscal year.
EBITDA margin for the fiscal year was 21.9%.
Net profit margin reached 11.5% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for MedCap. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

MedCap Stock Performance

MedCap has current market cap of SEK 8.3B (or $876M), and EV of SEK 8.3B (or $876M).

Market Cap Evolution

MedCap Stock Data

As of October 17, 2025, MedCap's stock price is SEK 555 (or $58).

See MedCap trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$876M	$876M	XXX	XXX	XXX	XXX	$1.89

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

MedCap Valuation Multiples

MedCap's trades at 4.6x EV/Revenue multiple, and 21.1x EV/EBITDA.

See valuation multiples for MedCap and 15K+ public comps

MedCap Financial Valuation Multiples

As of October 17, 2025, MedCap has market cap of $876M and EV of $876M.

Equity research analysts estimate MedCap's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

MedCap has a P/E ratio of 38.6x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$876M	XXX	$876M	XXX	XXX	XXX
EV (current)	$876M	XXX	$876M	XXX	XXX	XXX
EV/Revenue	4.2x	XXX	4.6x	XXX	XXX	XXX
EV/EBITDA	19.8x	XXX	21.1x	XXX	XXX	XXX
EV/EBIT	28.6x	XXX	34.6x	XXX	XXX	XXX
EV/Gross Profit	7.2x	XXX	n/a	XXX	XXX	XXX
P/E	38.6x	XXX	40.1x	XXX	XXX	XXX
EV/FCF	968.3x	XXX	28.3x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get MedCap Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

MedCap Margins & Growth Rates

MedCap's last 12 month revenue growth is 8%

MedCap's revenue per employee in the last FY averaged $0.7M, while opex per employee averaged $0.3M for the same period.

MedCap's rule of 40 is 30% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

MedCap's rule of X is 42% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for MedCap and other 15K+ public comps

MedCap Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	8%	XXX	10%	XXX	XXX	XXX
EBITDA Margin	21%	XXX	22%	XXX	XXX	XXX
EBITDA Growth	14%	XXX	12%	XXX	XXX	XXX
Rule of 40	30%	XXX	30%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	42%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.7M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.3M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	45%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial